Total Clarity Wealth Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$79.4 - $116.36 $1,191 - $1,745	15 New	15 $1,000
Q1 2022 Apr 29, 2022	SELL	$86.42 - $109.81 $1,296 - $1,647	-15 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$98.56 - $119.91 $9,856 - $11,991	-100 Reduced 86.96%	15 $2,000
Q3 2021 Oct 21, 2021	BUY	$91.91 - $110.37 $10,569 - $12,692	115 New	115 $13,000
Q2 2021 Jul 26, 2021	SELL	$86.24 - $95.92 $1,293 - $1,438	-15 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$71.83 - $95.48 $1,077 - $1,432	15 New	15 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.